HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michał Stefan Lach Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2020Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michał Stefan Lach Research Topics

Disease

3Uveal melanoma
01/2022 - 01/2020
3Neoplasms (Cancer)
07/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2022 - 07/2021
2Disease Progression
07/2021 - 01/2020
1Inflammation (Inflammations)
07/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Monosomy
01/2020
1Joint Diseases (Joint Disease)
06/2019

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2020
1Interleukin-2 (IL2)IBA
07/2021
1Proteins (Proteins, Gene)FDA Link
07/2021
1Interferon-gamma (Interferon, gamma)IBA
07/2021
1IonophoresIBA
01/2020
1salinomycinIBA
01/2020
1GemcitabineFDA Link
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1PlatinumIBA
01/2020
1human MIRN1247 microRNAIBA
01/2020
1human MIRN592 microRNAIBA
01/2020
1human MIRN346 microRNAIBA
01/2020
1human MIRN506 microRNAIBA
01/2020

Therapy/Procedure

1Therapeutics
06/2019